CE Research/Coverage Link Not Addressed In House Health Reform Draft
Executive Summary
The draft health reform legislation unveiled jointly by three House committees June 19 does not specifically address the use of comparative effectiveness research in treatment or coverage decisions, which should raise a red flag for the pharmaceutical industry